ANSMフランス供給不足情報（10月28日～11月3日）

ホーム > 供給不足情報 > 海外医薬品不足状況 > フランス > ANSMフランス供給不足情報（10月28日～11月3日）
StatusUpdateSpecialty
End of commercializationOct. 31, 2024Ribarivine Biogaran 200 mg/400 mg, film-coated tablet – [Ribavirin]
Supply tensionOct. 31, 2024Ultratechnekow FM, 2.15 – 43 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
Supply voltageOct. 31, 2024Tekcis 2-50 GBq, radiopharmaceutical generator – [sodium (molybdate (VI) [99 Mo] de)
ReleaseOct. 31, 2024Hydrocortisone Upjohn 500 mg, injectable preparation – [hydrocortisone (sodium hydrogen succinate)]
Supply tensionOct. 30, 2024Gardenal 200 mg/4 ml, powder and solvent for solution for injection – [phenobarbital sodium].
Supply tensionOct. 30, 2024Immunoglobulin normal human IV and SC (based on) – [Immunoglobulin normal human (IgG)
AvailabilityOct. 29, 2024NovoEight 3000 IU powder and solvent for injectable solution – [turoctocog alfa]
Out of stockOct. 29, 2024Kanokad 25 IU/mL factor IX, powder and solvent for solution for injection – Vials of 250 IU (10 ml) and 500 IU (20 ml)
Supply tensionOct. 28, 2024Ritalin LP 40 mg, sustained-release capsule – [methylphenidate (hydrochloride)
AvailabilityOct. 28, 2024Ritalin LP 20 mg and 30 mg, extended-release capsule – [methylphenidate (hydrochloride)]
Supply tensionOct. 25, 2024Cynomel 0.025 mg, scored tablets- [liothyronine sodium].
Marketing discontinuationOct. 25, 2024Heparin Choay 25 000 IU/5 ml, solution for injection, 1 glass vial(s) of 5 ml – [heparin sodium].
2024年11月4日
このページの先頭へ戻る